Please assess the completion status of the following clinical trial:

Trial Title: Pilot Evaluation of the Effect of Riboflavin Supplementation on Blood Pressure and Possible Effect Modification by the MTHFR C677T Genotype

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Healthy, aged between 18-70 years~* Has provided appropriate ethical consent for involvement in studies relating to genetics.~* Has available genotype data in the Keneba biobank needed for the current study~* Available for the duration of the intervention period~Exclusion Criteria:~Taking vitamin B/multivitamin supplements~* Ongoing pregnancy as confirmed by participant~* History of digestive, hepatic, renal or hematological disorders, dementia~* Epilepsy or taking anti-epileptic medications~* Glucose-6-phosphate dehydrogenase (G6PD) deficiency

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- treatment arm (Type: EXPERIMENTAL): 5mg Riboflavin pills
- Placebo arm (Type: PLACEBO_COMPARATOR): Placebo pills

Based on this trial design, predict the completion outcome and termination type (if applicable).